semaglutide and green poop Poop: Causes, When to Worry & What It Means – Bolt Pharmacy CONS: ⚠️ Gastrointestinal side effects:

GLP-1 medications have changed the conversation around weight management and metabolic health

However, the underlying mechanism of how these drugs regulate t...

A board-certified physician's guide to GLP-1 weight loss medications in 2026, including Foundayo (orforglipron), the first oral GLP-1 without fasting restrictions.

Review evidence on clotting risks, safe use, and guidance from clinical experts.

Cardiovascular disease (CVD) is the main cause of death and disability among people with type 2 diabetes.[2] Adults with type 2 diabetes are two to four times more likely to develop CVD than adults without diabetes.[3] The FDA's decision on semaglutide is based on results from the SUSTAIN 6 cardiovascular outcomes trial (CVOT), which examined the cardiovascular safety of adding Ozempic or placebo to standard-of-care in adults with type 2 diabetes and established cardiovascular disease